Hepatic Disease Research
Clinical activity is centred on liver disorders, with interest in conditions affecting hepatic structure and function, including alcoholic liver disease and chronic viral hepatitis B.
- Alcoholic liver disease
- Chronic viral hepatitis B
The sponsor’s research landscape includes therapeutic evaluation in chronic liver disease settings where preservation of liver health and symptom control are key clinical concerns.
Metabolic Liver Disease
Another major area of interest is metabolic dysfunction-associated steatotic liver disease, including MASH and related metabolic liver inflammation.
- MASLD / MASH
- Metabolic dysfunction-associated steatohepatitis
These studies reflect a focus on liver conditions linked to metabolic dysfunction and progressive steatotic injury.
Supportive Liver Care
The funded research also addresses supportive treatment in liver disease, with attention to therapies used alongside standard of care management.
- Adjunctive liver therapy
- Maintenance of hepatic function
Clinical interest extends to oral and liquid formulations evaluated in routine liver disease care.
Gastroenterology and Internal Medicine
The sponsor’s trial activity sits within broader gastroenterology and internal medicine domains, where liver-related outcomes are assessed in patients with complex chronic disease.
- Digestive system disorders
- Chronic disease management
This includes clinical interest in therapeutic options relevant to long-term management of hepatic and metabolic conditions.
